|
1
|
Bohanes P, Yang D, Chhibar RS, Labonte MJ,
Winder T, Ning Y, Gerger A, Benhaim L, Paez D, Wakatsuki T, et al:
Influence of sex on the survival of patients with esophageal
cancer. J Clin Oncol. 30:2265–2272. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Abnet CC, Arnold M and Wei WQ:
Epidemiology of esophageal squamous cell carcinoma.
Gastroenterology. 154:360–373. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Matsushima K, Isomoto H, Yamaguchi N,
Inoue N, Machida H, Nakayama T, Hayashi T, Kunizaki M, Hidaka S,
Nagayasu T, et al: MiRNA-205 modulates cellular invasion and
migration via regulating zinc finger E-box binding homeobox 2
expression in esophageal squamous cell carcinoma cells. J Transl
Med. 9:302011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nagaraja V and Eslick GD: Forthcoming
prognostic markers for esophageal cancer: A systematic review and
meta-analysis. J Gastrointest Oncol. 5:67–76. 2014.PubMed/NCBI
|
|
6
|
Pera M, Manterola C, Vidal O and Grande L:
Epidemiology of esophageal adenocarcinoma. J Surg Oncol.
92:151–159. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fan YJ, Song X, Li JL, Li XM, Liu B, Wang
R, Fan ZM and Wang LD: Esophageal and gastric cardia cancers on
4238 Chinese patients residing in municipal and rural regions: a
histopathological comparison during 24-year period. World J Surg.
32:1980–1988. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pennathur A, Gibson MK, Jobe BA and
Luketich JD: Oesophageal carcinoma. Lancet. 381:400–412. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Enzinger PC and Mayer RJ: Esophageal
cancer. N Engl J Med. 349:2241–2252. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Domper Arnal MJ, Ferrandez Arenas A and
Lanas Arbeloa A: Esophageal cancer: Risk factors, screening and
endoscopic treatment in Western and Eastern countries. World J
Gastroenterol. 21:7933–7943. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang J, Zhu Z, Liu Y, Jin X, Xu Z, Yu Q
and Li K: Diagnostic value of multiple tumor markers for patients
with esophageal carcinoma. PLoS One. 10:e01169512015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
He Z, Liu Z, Liu M, Guo C, Xu R, Li F, Liu
A, Yang H, Shen L, Wu Q, et al: Efficacy of endoscopic screening
for esophageal cancer in China (ESECC): Design and preliminary
results of a population-based randomised controlled trial. Gut.
68:198–206. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li J, Xu R, Liu M, Cai H, Cao C, Liu F, Li
F, Guo C, Pan Y, He Z and Ke Y: Lugol chromoendoscopy detects
esophageal dysplasia with low levels of sensitivity in a high-risk
region of china. Clin Gastroenterol Hepatol. 16:1585–1592. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Smyth EC, Lagergren J, Fitzgerald RC,
Lordick F, Shah MA, Lagergren P and Cunningham D: Oesophageal
cancer. Nat Rev Dis Primers. 3:170482017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang Y, Wang F, Ning N, Chen Q, Yang Z,
Guo Y, Xu D, Zhang D, Zhan T and Cui W: Patterns of circulating
tumor cells identified by CEP8, CK and CD45 in pancreatic cancer.
Int J Cancer. 136:1228–1233. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Marx V: Tracking metastasis and tricking
cancer. Nature. 494:133–136. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kim MY, Oskarsson T, Acharyya S, Nguyen
DX, Zhang XH, Norton L and Massagué J: Tumor self-seeding by
circulating cancer cells. Cell. 139:1315–1326. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pierga JY, Bidard FC, Mathiot C, Brain E,
Delaloge S, Giachetti S, de Cremoux P, Salmon R, Vincent-Salomon A
and Marty M: Circulating tumor cell detection predicts early
metastatic relapse after neoadjuvant chemotherapy in large operable
and locally advanced breast cancer in a phase II randomized trial.
Clin Cancer Res. 14:7004–7010. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Matsushita D, Uenosono Y, Arigami T,
Yanagita S, Nishizono Y, Hagihara T, Hirata M, Haraguchi N, Arima
H, Kijima Y, et al: Clinical significance of circulating tumor
cells in peripheral blood of patients with esophageal squamous cell
carcinoma. Ann Surg Oncol. 22:3674–3680. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Qiao Y, Li J, Shi C, Wang W, Qu X, Xiong
M, Sun Y, Li D, Zhao X and Zhang D: Prognostic value of circulating
tumor cells in the peripheral blood of patients with esophageal
squamous cell carcinoma. Onco Targets Ther. 10:1363–1373. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lianidou ES and Markou A: Circulating
tumor cells as emerging tumor biomarkers in breast cancer. Clin
Chem Lab Med. 49:1579–1590. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Swennenhuis JF, van Dalum G, Zeune LL and
Terstappen LW: Improving the CellSearch(R) system.
Expert Rev Mol Diagn. 16:1291–1305. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Andree KC, van Dalum G and Terstappen LW:
Challenges in circulating tumor cell detection by the CellSearch
system. Mol Oncol. 10:395–407. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sheng Y, Wang T, Li H, Zhang Z, Chen J, He
C, Li Y, Lv Y, Zhang J, Xu C, et al: Comparison of analytic
performances of Cellsearch and iFISH approach in detecting
circulating tumor cells. Oncotarget. 8:8801–8806. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Reeh M, Effenberger KE, Koenig AM,
Riethdorf S, Eichstädt D, Vettorazzi E, Uzunoglu FG, Vashist YK,
Izbicki JR, Pantel K and Bockhorn M: Circulating tumor cells as a
biomarker for preoperative prognostic staging in patients with
esophageal cancer. Ann Surg. 261:1124–1130. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Stephen Edge DRB and Carolyn C: AJCC
Cancer Staging Manual. 7th. Edge S, Byrd DR, Compton CC, Fritz AG,
Greene F and Trotti A: Springer; New York, NY: 2010
|
|
27
|
Liu X, Zhang Z, Zhang B, Zheng Y, Zheng C,
Liu B, Zheng S, Dong K and Dong R: Circulating tumor cells
detection in neuroblastoma patients by EpCAM-independent enrichment
and immunostaining-fluorescence in situ hybridization.
EBioMedicine. 35:244–250. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wu W, Zhang Z, Gao XH, Shen Z, Jing Y, Lu
H, Li H, Yang X, Cui X, Li Y, et al: Clinical significance of
detecting circulating tumor cells in colorectal cancer using
subtraction enrichment and immunostaining-fluorescence in situ
hybridization (SE-iFISH). Oncotarget. 8:21639–21649.
2017.PubMed/NCBI
|
|
29
|
Xu L, Jia S, Li H, Yu Y, Liu G, Wu Y, Liu
X, Liu C, Zhou Y, Zhang Z and Sheng Y: Characterization of
circulating tumor cells in newly diagnosed breast cancer. Oncol
Lett. 15:2522–2528. 2018.PubMed/NCBI
|
|
30
|
Aceto N, Bardia A, Miyamoto DT, Donaldson
MC, Wittner BS, Spencer JA, Yu M, Pely A, Engstrom A, Zhu H, et al:
Circulating tumor cell clusters are oligoclonal precursors of
breast cancer metastasis. Cell. 158:1110–1122. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Therasse P, Arbuck SG, Eisenhauer EA,
Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van
Oosterom AT, Christian MC and Gwyther SG: New guidelines to
evaluate the response to treatment in solid tumors. European
Organization for Research and Treatment of Cancer, National Cancer
Institute of the United States, National Cancer Institute of
Canada. J Natl Cancer Inst. 92:205–216. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Nagrath S, Sequist LV, Maheswaran S, Bell
DW, Irimia D, Ulkus L, Smith MR, Kwak EL, Digumarthy S, Muzikansky
A, et al: Isolation of rare circulating tumour cells in cancer
patients by microchip technology. Nature. 450:1235–1239. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Masuda T, Hayashi N, Iguchi T, Ito S,
Eguchi H and Mimori K: Clinical and biological significance of
circulating tumor cells in cancer. Mol Oncol. 10:408–417. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yap TA, Lorente D, Omlin A, Olmos D and de
Bono JS: Circulating tumor cells: A multifunctional biomarker. Clin
Cancer Res. 20:2553–2568. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cristofanilli M, Budd GT, Ellis MJ,
Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ,
Terstappen LW and Hayes DF: Circulating tumor cells, disease
progression and survival in metastatic breast cancer. N Engl J Med.
351:781–791. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Vona G, Sabile A, Louha M, Sitruk V,
Romana S, Schütze K, Capron F, Franco D, Pazzagli M, Vekemans M, et
al: Isolation by size of epithelial tumor cells: A new method for
the immunomorphological and molecular characterization of
circulatingtumor cells. Am J Pathol. 156:57–63. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Xue F, Shi S, Zhang Z, Xu C, Zheng J, Qin
T, Qian Z, Zhao X, Tong Y, Xia L and Xia Q: Application of a novel
liquid biopsy in patients with hepatocellular carcinoma undergoing
liver transplantation. Oncol Lett. 15:5481–5488. 2018.PubMed/NCBI
|
|
38
|
Roach T, Slater S, Koval M, White L, Cahir
McFarland ED, Okumura M, Thomas M and Brown E: CD45 regulates Src
family member kinase activity associated with macrophage
integrin-mediated adhesion. Curr Biol. 7:408–417. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Court CM, Ankeny JS, Hou S, Tseng HR and
Tomlinson JS: Improving pancreatic cancer diagnosis using
circulating tumor cells: Prospects for staging and single-cell
analysis. Expert Rev Mol Diagn. 15:1491–1504. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ge F, Zhang H, Wang DD, Li L and Lin PP:
Enhanced detection and comprehensive in situ phenotypic
characterization of circulating and disseminated heteroploid
epithelial and glioma tumor cells. Oncotarget. 6:27049–27064. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chen W, Li Y, Yuan D, Peng Y and Qin J:
Practical value of identifying circulating tumor cells to evaluate
esophageal squamous cell carcinoma staging and treatment efficacy.
Thorac Cancer. 9:956–966. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Han D, Chen K, Che J, Hang J and Li H:
Detection of epithelial-mesenchymal transition status of
circulating tumor cells in patients with esophageal squamous
carcinoma. Biomed Res Int. 2018:76101542018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wang J, Wang K, Xu J, Huang J and Zhang T:
Prognostic significance of circulating tumor cells in
non-small-cell lung cancer patients: A meta-analysis. PLoS One.
8:e780702013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Funaki S, Sawabata N, Abulaiti A, Nakagiri
T, Shintani Y, Inoue M, Minami M and Okumura M: Significance of
tumour vessel invasion in determining the morphology of isolated
tumour cells in the pulmonary vein in non-small-cell lung cancer.
Eur J Cardiothorac Surg. 43:1126–1130. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yu M, Bardia A, Wittner BS, Stott SL, Smas
ME, Ting DT, Isakoff SJ, Ciciliano JC, Wells MN, Shah AM, et al:
Circulating breast tumor cells exhibit dynamic changes in
epithelial and mesenchymal composition. Science. 339:580–584. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Jolly MK, Boareto M, Huang B, Jia D, Lu M,
Ben-Jacob E, Onuchic JN and Levine H: Implications of the Hybrid
epithelial/mesenchymal phenotype in metastasis. Front Oncol.
5:1552015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Gao Y, Ni X, Guo H, Su Z, Ba Y, Tong Z,
Guo Z, Yao X, Chen X, Yin J, et al: Single-cell sequencing
deciphers a convergent evolution of copy number alterations from
primary to circulating tumor cells. Genome Res. 27:1312–1322. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
D'Avola D, Villacorta-Martin C,
Martins-Filho SN, Craig A, Labgaa I, von Felden J, Kimaada A,
Bonaccorso A, Tabrizian P, Hartmann BM, et al: High-density single
cell mRNA sequencing to characterize circulating tumor cells in
hepatocellular carcinoma. Sci Rep. 8:115702018. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zhu Z, Qiu S, Shao K and Hou Y: Progress
and challenges of sequencing and analyzing circulating tumor cells.
Cell Biol Toxicol. 34:405–415. 2017. View Article : Google Scholar : PubMed/NCBI
|
